Global Non-invasive Prenatal Diagnostics Databank Market Report
The Non-invasive Prenatal Diagnostics market was valued at $4,215.6 Million in 2022, and is projected to reach $9,035.7 Million by 2031 growing at a CAGR of 8.90% from 2023 to 2031. 13-24 Weeks segment is expected to be the highest contributor to this market, with $2,221.5 Million in 2022, and is anticipated to reach $4,609.1 Million by 2031, registering a CAGR of 8.50%. 0-12 Weeks segment is anticipated to reach $2,263.2 Million by 2031 with the highest CAGR of 9.32%. 13-24 Weeks and 0-12 Weeks segments collectively expected to account for about 76.9% share of the Non-invasive Prenatal Diagnostics market in 2022, with the former constituting around 52.7% share. 0-12 Weeks and 25-36 Weeks segments are expected to witness significant growth rates at a CAGR of 9.32% and 9.32% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 47.3% in the overall Non-invasive Prenatal Diagnostics market in 2022, and is anticipated to reach 49.0% by 2031.
- 1. Global Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 1.1. Overview
- 1.2. 0-12 Weeks
- 1.2.1 0-12 Weeks Market, By Region
- 1.2.1.1 North America 0-12 Weeks Market, By Country
- 1.2.1.2 Europe 0-12 Weeks Market, By Country
- 1.2.1.3 Asia-Pacific 0-12 Weeks Market, By Country
- 1.2.1.4 Rest of World 0-12 Weeks Market, By Country
- 1.3. 13-24 Weeks
- 1.3.1 13-24 Weeks Market, By Region
- 1.3.1.1 North America 13-24 Weeks Market, By Country
- 1.3.1.2 Europe 13-24 Weeks Market, By Country
- 1.3.1.3 Asia-Pacific 13-24 Weeks Market, By Country
- 1.3.1.4 Rest of World 13-24 Weeks Market, By Country
- 1.4. 25-36 Weeks
- 1.4.1 25-36 Weeks Market, By Region
- 1.4.1.1 North America 25-36 Weeks Market, By Country
- 1.4.1.2 Europe 25-36 Weeks Market, By Country
- 1.4.1.3 Asia-Pacific 25-36 Weeks Market, By Country
- 1.4.1.4 Rest of World 25-36 Weeks Market, By Country
- 2. Global Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 2.1. Overview
- 2.2. High & Average Risk
- 2.2.1 High & Average Risk Market, By Region
- 2.2.1.1 North America High & Average Risk Market, By Country
- 2.2.1.2 Europe High & Average Risk Market, By Country
- 2.2.1.3 Asia-Pacific High & Average Risk Market, By Country
- 2.2.1.4 Rest of World High & Average Risk Market, By Country
- 2.3. Low Risk
- 2.3.1 Low Risk Market, By Region
- 2.3.1.1 North America Low Risk Market, By Country
- 2.3.1.2 Europe Low Risk Market, By Country
- 2.3.1.3 Asia-Pacific Low Risk Market, By Country
- 2.3.1.4 Rest of World Low Risk Market, By Country
- 3. Global Non-invasive Prenatal Diagnostics Market, By Method
- 3.1. Overview
- 3.2. Ultrasound Detection
- 3.2.1 Ultrasound Detection Market, By Region
- 3.2.1.1 North America Ultrasound Detection Market, By Country
- 3.2.1.2 Europe Ultrasound Detection Market, By Country
- 3.2.1.3 Asia-Pacific Ultrasound Detection Market, By Country
- 3.2.1.4 Rest of World Ultrasound Detection Market, By Country
- 3.3. Biochemical Screening Tests
- 3.3.1 Biochemical Screening Tests Market, By Region
- 3.3.1.1 North America Biochemical Screening Tests Market, By Country
- 3.3.1.2 Europe Biochemical Screening Tests Market, By Country
- 3.3.1.3 Asia-Pacific Biochemical Screening Tests Market, By Country
- 3.3.1.4 Rest of World Biochemical Screening Tests Market, By Country
- 3.4. Cell-free DNA in Maternal Plasma Tests
- 3.4.1 Cell-free DNA in Maternal Plasma Tests Market, By Region
- 3.4.1.1 North America Cell-free DNA in Maternal Plasma Tests Market, By Country
- 3.4.1.2 Europe Cell-free DNA in Maternal Plasma Tests Market, By Country
- 3.4.1.3 Asia-Pacific Cell-free DNA in Maternal Plasma Tests Market, By Country
- 3.4.1.4 Rest of World Cell-free DNA in Maternal Plasma Tests Market, By Country
- 4. Global Non-invasive Prenatal Diagnostics Market, By Technology
- 4.1. Overview
- 4.2. NGS
- 4.2.1 NGS Market, By Region
- 4.2.1.1 North America NGS Market, By Country
- 4.2.1.2 Europe NGS Market, By Country
- 4.2.1.3 Asia-Pacific NGS Market, By Country
- 4.2.1.4 Rest of World NGS Market, By Country
- 4.3. Array Technology
- 4.3.1 Array Technology Market, By Region
- 4.3.1.1 North America Array Technology Market, By Country
- 4.3.1.2 Europe Array Technology Market, By Country
- 4.3.1.3 Asia-Pacific Array Technology Market, By Country
- 4.3.1.4 Rest of World Array Technology Market, By Country
- 4.4. PCR
- 4.4.1 PCR Market, By Region
- 4.4.1.1 North America PCR Market, By Country
- 4.4.1.2 Europe PCR Market, By Country
- 4.4.1.3 Asia-Pacific PCR Market, By Country
- 4.4.1.4 Rest of World PCR Market, By Country
- 4.5. Other Technologies
- 4.5.1 Other Technologies Market, By Region
- 4.5.1.1 North America Other Technologies Market, By Country
- 4.5.1.2 Europe Other Technologies Market, By Country
- 4.5.1.3 Asia-Pacific Other Technologies Market, By Country
- 4.5.1.4 Rest of World Other Technologies Market, By Country
- 5. Global Non-invasive Prenatal Diagnostics Market, By Region
- 5.1. Overview
- 5.2. North America
- 5.2.1 North America Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.2.2 North America Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.2.3 North America Non-invasive Prenatal Diagnostics Market, By Method
- 5.2.4 North America Non-invasive Prenatal Diagnostics Market, By Technology
- 5.2.5 North America Non-invasive Prenatal Diagnostics Market, By Country
- 5.2.5.1 U.S.
- 5.2.5.1.1 U.S. Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.2.5.1.2 U.S. Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.2.5.1.3 U.S. Non-invasive Prenatal Diagnostics Market, By Method
- 5.2.5.1.4 U.S. Non-invasive Prenatal Diagnostics Market, By Technology
- 5.2.5.2 Canada
- 5.2.5.2.1 Canada Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.2.5.2.2 Canada Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.2.5.2.3 Canada Non-invasive Prenatal Diagnostics Market, By Method
- 5.2.5.2.4 Canada Non-invasive Prenatal Diagnostics Market, By Technology
- 5.3. Europe
- 5.3.1 Europe Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.3.2 Europe Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.3.3 Europe Non-invasive Prenatal Diagnostics Market, By Method
- 5.3.4 Europe Non-invasive Prenatal Diagnostics Market, By Technology
- 5.3.5 Europe Non-invasive Prenatal Diagnostics Market, By Country
- 5.3.5.1 Germany
- 5.3.5.1.1 Germany Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.3.5.1.2 Germany Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.3.5.1.3 Germany Non-invasive Prenatal Diagnostics Market, By Method
- 5.3.5.1.4 Germany Non-invasive Prenatal Diagnostics Market, By Technology
- 5.3.5.2 U.K.
- 5.3.5.2.1 U.K. Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.3.5.2.2 U.K. Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.3.5.2.3 U.K. Non-invasive Prenatal Diagnostics Market, By Method
- 5.3.5.2.4 U.K. Non-invasive Prenatal Diagnostics Market, By Technology
- 5.3.5.3 France
- 5.3.5.3.1 France Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.3.5.3.2 France Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.3.5.3.3 France Non-invasive Prenatal Diagnostics Market, By Method
- 5.3.5.3.4 France Non-invasive Prenatal Diagnostics Market, By Technology
- 5.3.5.4 Italy
- 5.3.5.4.1 Italy Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.3.5.4.2 Italy Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.3.5.4.3 Italy Non-invasive Prenatal Diagnostics Market, By Method
- 5.3.5.4.4 Italy Non-invasive Prenatal Diagnostics Market, By Technology
- 5.3.5.5 Spain
- 5.3.5.5.1 Spain Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.3.5.5.2 Spain Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.3.5.5.3 Spain Non-invasive Prenatal Diagnostics Market, By Method
- 5.3.5.5.4 Spain Non-invasive Prenatal Diagnostics Market, By Technology
- 5.3.5.6 Rest of Europe
- 5.3.5.6.1 Rest of Europe Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.3.5.6.2 Rest of Europe Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.3.5.6.3 Rest of Europe Non-invasive Prenatal Diagnostics Market, By Method
- 5.3.5.6.4 Rest of Europe Non-invasive Prenatal Diagnostics Market, By Technology
- 5.4. Asia-Pacific
- 5.4.1 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.4.2 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.4.3 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Method
- 5.4.4 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Technology
- 5.4.5 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Country
- 5.4.5.1 China
- 5.4.5.1.1 China Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.4.5.1.2 China Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.4.5.1.3 China Non-invasive Prenatal Diagnostics Market, By Method
- 5.4.5.1.4 China Non-invasive Prenatal Diagnostics Market, By Technology
- 5.4.5.2 Japan
- 5.4.5.2.1 Japan Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.4.5.2.2 Japan Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.4.5.2.3 Japan Non-invasive Prenatal Diagnostics Market, By Method
- 5.4.5.2.4 Japan Non-invasive Prenatal Diagnostics Market, By Technology
- 5.4.5.3 South Korea
- 5.4.5.3.1 South Korea Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.4.5.3.2 South Korea Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.4.5.3.3 South Korea Non-invasive Prenatal Diagnostics Market, By Method
- 5.4.5.3.4 South Korea Non-invasive Prenatal Diagnostics Market, By Technology
- 5.4.5.4 India
- 5.4.5.4.1 India Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.4.5.4.2 India Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.4.5.4.3 India Non-invasive Prenatal Diagnostics Market, By Method
- 5.4.5.4.4 India Non-invasive Prenatal Diagnostics Market, By Technology
- 5.4.5.5 Singapore
- 5.4.5.5.1 Singapore Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.4.5.5.2 Singapore Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.4.5.5.3 Singapore Non-invasive Prenatal Diagnostics Market, By Method
- 5.4.5.5.4 Singapore Non-invasive Prenatal Diagnostics Market, By Technology
- 5.4.5.6 Rest of Asia
- 5.4.5.6.1 Rest of Asia Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.4.5.6.2 Rest of Asia Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.4.5.6.3 Rest of Asia Non-invasive Prenatal Diagnostics Market, By Method
- 5.4.5.6.4 Rest of Asia Non-invasive Prenatal Diagnostics Market, By Technology
- 5.5. Rest of World
- 5.5.1 Rest of World Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.5.2 Rest of World Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.5.3 Rest of World Non-invasive Prenatal Diagnostics Market, By Method
- 5.5.4 Rest of World Non-invasive Prenatal Diagnostics Market, By Technology
- 5.5.5 Rest of World Non-invasive Prenatal Diagnostics Market, By Country
- 5.5.5.1 Brazil
- 5.5.5.1.1 Brazil Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.5.5.1.2 Brazil Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.5.5.1.3 Brazil Non-invasive Prenatal Diagnostics Market, By Method
- 5.5.5.1.4 Brazil Non-invasive Prenatal Diagnostics Market, By Technology
- 5.5.5.2 Mexico
- 5.5.5.2.1 Mexico Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.5.5.2.2 Mexico Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.5.5.2.3 Mexico Non-invasive Prenatal Diagnostics Market, By Method
- 5.5.5.2.4 Mexico Non-invasive Prenatal Diagnostics Market, By Technology
- 5.5.5.3 South Africa
- 5.5.5.3.1 South Africa Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.5.5.3.2 South Africa Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.5.5.3.3 South Africa Non-invasive Prenatal Diagnostics Market, By Method
- 5.5.5.3.4 South Africa Non-invasive Prenatal Diagnostics Market, By Technology
- 5.5.5.4 Australia
- 5.5.5.4.1 Australia Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.5.5.4.2 Australia Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.5.5.4.3 Australia Non-invasive Prenatal Diagnostics Market, By Method
- 5.5.5.4.4 Australia Non-invasive Prenatal Diagnostics Market, By Technology
- 5.5.5.5 ROW Countries
- 5.5.5.5.1 ROW Countries Non-invasive Prenatal Diagnostics Market, By Gestation Period
- 5.5.5.5.2 ROW Countries Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
- 5.5.5.5.3 ROW Countries Non-invasive Prenatal Diagnostics Market, By Method
- 5.5.5.5.4 ROW Countries Non-invasive Prenatal Diagnostics Market, By Technology
- ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD LIST OF TABLES
- TABLE 1. Global Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 2. 0-12 Weeks Market Value, By Region, 2022-2031, Million USD
- TABLE 3. North America 0-12 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 4. Europe 0-12 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 5. Asia-Pacific 0-12 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 6. Rest of World 0-12 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 7. 13-24 Weeks Market Value, By Region, 2022-2031, Million USD
- TABLE 8. North America 13-24 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 9. Europe 13-24 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 10. Asia-Pacific 13-24 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 11. Rest of World 13-24 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 12. 25-36 Weeks Market Value, By Region, 2022-2031, Million USD
- TABLE 13. North America 25-36 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 14. Europe 25-36 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 15. Asia-Pacific 25-36 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 16. Rest of World 25-36 Weeks Market Value, By Country, 2022-2031, Million USD
- TABLE 17. Global Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 18. High & Average Risk Market Value, By Region, 2022-2031, Million USD
- TABLE 19. North America High & Average Risk Market Value, By Country, 2022-2031, Million USD
- TABLE 20. Europe High & Average Risk Market Value, By Country, 2022-2031, Million USD
- TABLE 21. Asia-Pacific High & Average Risk Market Value, By Country, 2022-2031, Million USD
- TABLE 22. Rest of World High & Average Risk Market Value, By Country, 2022-2031, Million USD
- TABLE 23. Low Risk Market Value, By Region, 2022-2031, Million USD
- TABLE 24. North America Low Risk Market Value, By Country, 2022-2031, Million USD
- TABLE 25. Europe Low Risk Market Value, By Country, 2022-2031, Million USD
- TABLE 26. Asia-Pacific Low Risk Market Value, By Country, 2022-2031, Million USD
- TABLE 27. Rest of World Low Risk Market Value, By Country, 2022-2031, Million USD
- TABLE 28. Global Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 29. Ultrasound Detection Market Value, By Region, 2022-2031, Million USD
- TABLE 30. North America Ultrasound Detection Market Value, By Country, 2022-2031, Million USD
- TABLE 31. Europe Ultrasound Detection Market Value, By Country, 2022-2031, Million USD
- TABLE 32. Asia-Pacific Ultrasound Detection Market Value, By Country, 2022-2031, Million USD
- TABLE 33. Rest of World Ultrasound Detection Market Value, By Country, 2022-2031, Million USD
- TABLE 34. Biochemical Screening Tests Market Value, By Region, 2022-2031, Million USD
- TABLE 35. North America Biochemical Screening Tests Market Value, By Country, 2022-2031, Million USD
- TABLE 36. Europe Biochemical Screening Tests Market Value, By Country, 2022-2031, Million USD
- TABLE 37. Asia-Pacific Biochemical Screening Tests Market Value, By Country, 2022-2031, Million USD
- TABLE 38. Rest of World Biochemical Screening Tests Market Value, By Country, 2022-2031, Million USD
- TABLE 39. Cell-free DNA in Maternal Plasma Tests Market Value, By Region, 2022-2031, Million USD
- TABLE 40. North America Cell-free DNA in Maternal Plasma Tests Market Value, By Country, 2022-2031, Million USD
- TABLE 41. Europe Cell-free DNA in Maternal Plasma Tests Market Value, By Country, 2022-2031, Million USD
- TABLE 42. Asia-Pacific Cell-free DNA in Maternal Plasma Tests Market Value, By Country, 2022-2031, Million USD
- TABLE 43. Rest of World Cell-free DNA in Maternal Plasma Tests Market Value, By Country, 2022-2031, Million USD
- TABLE 44. Global Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 45. NGS Market Value, By Region, 2022-2031, Million USD
- TABLE 46. North America NGS Market Value, By Country, 2022-2031, Million USD
- TABLE 47. Europe NGS Market Value, By Country, 2022-2031, Million USD
- TABLE 48. Asia-Pacific NGS Market Value, By Country, 2022-2031, Million USD
- TABLE 49. Rest of World NGS Market Value, By Country, 2022-2031, Million USD
- TABLE 50. Array Technology Market Value, By Region, 2022-2031, Million USD
- TABLE 51. North America Array Technology Market Value, By Country, 2022-2031, Million USD
- TABLE 52. Europe Array Technology Market Value, By Country, 2022-2031, Million USD
- TABLE 53. Asia-Pacific Array Technology Market Value, By Country, 2022-2031, Million USD
- TABLE 54. Rest of World Array Technology Market Value, By Country, 2022-2031, Million USD
- TABLE 55. PCR Market Value, By Region, 2022-2031, Million USD
- TABLE 56. North America PCR Market Value, By Country, 2022-2031, Million USD
- TABLE 57. Europe PCR Market Value, By Country, 2022-2031, Million USD
- TABLE 58. Asia-Pacific PCR Market Value, By Country, 2022-2031, Million USD
- TABLE 59. Rest of World PCR Market Value, By Country, 2022-2031, Million USD
- TABLE 60. Other Technologies Market Value, By Region, 2022-2031, Million USD
- TABLE 61. North America Other Technologies Market Value, By Country, 2022-2031, Million USD
- TABLE 62. Europe Other Technologies Market Value, By Country, 2022-2031, Million USD
- TABLE 63. Asia-Pacific Other Technologies Market Value, By Country, 2022-2031, Million USD
- TABLE 64. Rest of World Other Technologies Market Value, By Country, 2022-2031, Million USD
- TABLE 65. Global Non-invasive Prenatal Diagnostics Market Value, By Region, 2022-2031, Million USD
- TABLE 66. North America Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 67. North America Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 68. North America Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 69. North America Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 70. North America Non-invasive Prenatal Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 71. U.S. Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 72. U.S. Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 73. U.S. Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 74. U.S. Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 75. Canada Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 76. Canada Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 77. Canada Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 78. Canada Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 79. Europe Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 80. Europe Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 81. Europe Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 82. Europe Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 83. Europe Non-invasive Prenatal Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 84. Germany Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 85. Germany Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 86. Germany Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 87. Germany Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 88. U.K. Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 89. U.K. Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 90. U.K. Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 91. U.K. Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 92. France Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 93. France Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 94. France Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 95. France Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 96. Italy Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 97. Italy Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 98. Italy Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 99. Italy Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 100. Spain Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 101. Spain Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 102. Spain Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 103. Spain Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 104. Rest of Europe Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 105. Rest of Europe Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 106. Rest of Europe Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 107. Rest of Europe Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 108. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 109. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 110. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 111. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 112. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 113. China Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 114. China Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 115. China Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 116. China Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 117. Japan Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 118. Japan Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 119. Japan Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 120. Japan Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 121. South Korea Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 122. South Korea Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 123. South Korea Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 124. South Korea Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 125. India Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 126. India Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 127. India Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 128. India Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 129. Singapore Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 130. Singapore Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 131. Singapore Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 132. Singapore Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 133. Rest of Asia Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 134. Rest of Asia Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 135. Rest of Asia Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 136. Rest of Asia Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 137. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 138. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 139. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 140. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 141. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 142. Brazil Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 143. Brazil Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 144. Brazil Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 145. Brazil Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 146. Mexico Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 147. Mexico Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 148. Mexico Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 149. Mexico Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 150. South Africa Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 151. South Africa Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 152. South Africa Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 153. South Africa Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 154. Australia Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 155. Australia Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 156. Australia Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 157. Australia Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- TABLE 158. ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
- TABLE 159. ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
- TABLE 160. ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
- TABLE 161. ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
- ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook